MICHAEL POWELL - 16 Jun 2021 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Kleem Chaudhary, attorney-in-fact
Issuer symbol
N/A
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 21:18:03 UTC
Next filing
10 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +10,030 $0.000000 10,030 16 Jun 2021 Common Stock 10,030 $6.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 16, 2021 with respect to 10,030 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.